10.1 | Production and post-production information system | 0 |
10.2 | Collecting production and post-production information | 0 |
10.3 | Examining the information collected | 1 |
10.4 | Responding to safety-relevant information | 0 |
4.1 | Risk management kept running across the life cycle | 3 |
4.2 | Top management responsibilities for risk | 0 |
4.3 | Competence of the people doing risk management work | 0 |
4.4 | Plan for risk management | 0 |
4.5 | File for risk management | 0 |
5.1 | Carrying out the risk analysis and recording it | 0 |
5.2 | Intended use and foreseeable misuse written down | 1 |
5.3 | Safety related characteristics of the device identified | 0 |
5.4 | Hazards and hazardous situations identified | 1 |
5.5 | Estimating risk for each hazardous situation | 0 |
6 | Judging estimated risk against the acceptability criteria | 0 |
7.1 | Analysing the options for risk control | 2 |
7.2 | Implementation and verification of controls | 1 |
7.3 | Residual risk evaluation | 0 |
7.4 | Weighing benefit against a residual risk | 1 |
7.5 | Risks that the control measures themselves create | 0 |
7.6 | Confirming that risk control is complete | 0 |
8 | Judging the overall residual risk | 1 |
9 | Review of risk management before commercial release | 0 |
Annex-A | Annex A (informative): rationale for the requirements | 0 |
Annex-B | Annex B (informative): overview of the risk management process | 0 |
Annex-C | Annex C (informative): fundamental risk concepts | 0 |
Annex-ZA | Annex ZA and MDR presumption of conformity | 0 |
Annex-ZB | IVDR correspondence annex for IVD devices | 0 |
Clause-1 | Scope of the risk management standard | 0 |
Clause-2 | No normative references cited | 0 |
Clause-3 | Terms and definitions used throughout | 0 |
ZA.3(a) | MDR GSPR 3(a): risk management plan | 0 |
ZA.3(b) | MDR GSPR 3(b): hazard identification and analysis | 0 |
ZA.3(c) | MDR GSPR 3(c): risk estimation and evaluation | 0 |
ZA.3(d) | MDR GSPR 3(d): elimination or control of risks | 0 |
ZA.3(e) | MDR GSPR 3(e): production and post-market impact | 0 |
ZA.3(f) | MDR GSPR 3(f): amending control measures | 0 |
ZA.3-first | MDR GSPR 3: risk management system | 0 |
ZA.3-second | MDR GSPR 3: lifecycle risk management | 0 |
ZA.4(a) | MDR GSPR 4(a): safe design and manufacture | 0 |
ZA.4(b) | MDR GSPR 4(b): protective measures and alarms | 0 |
ZA.4(c) | MDR GSPR 4(c): information for safety and training | 0 |
ZA.4-first | MDR GSPR 4: safety principles and residual risk | 0 |
ZA.4-last | MDR GSPR 4: disclosure of residual risk | 0 |
ZA.5(a) | MDR GSPR 5: design for patient safety | 0 |
ZA.5(b) | MDR GSPR 5: characteristics of intended users | 0 |
ZA.8 | MDR GSPR 8: risk reduction and acceptability | 0 |
ZA.9 | MDR GSPR 9: products without a medical purpose (Annex XVI) | 0 |
ZB.3(a) | IVDR GSPR 3(a): a risk management plan for every device | 0 |
ZB.3(b) | IVDR GSPR 3(b): hazard identification and analysis | 0 |
ZB.3(c) | IVDR GSPR 3(c): risk estimation for use and misuse | 0 |
ZB.3(d) | IVDR GSPR 3(d): risk elimination or control | 0 |
ZB.3(e) | IVDR GSPR 3(e): production and post-market information | 0 |
ZB.3(f) | IVDR GSPR 3(f): amending control measures after review | 0 |
ZB.3-first | IVDR GSPR 3: risk management system in place | 0 |
ZB.3-second | IVDR GSPR 3: continuous iterative lifecycle process | 0 |
ZB.4(a) | IVDR GSPR 4(a): risk removal by safe design | 0 |
ZB.4(b) | IVDR GSPR 4(b): protection measures and alarms | 0 |
ZB.4-first | IVDR GSPR 4: safety principles and control priority | 0 |